Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
about
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy.Usefulness of palliative prognostic score in the treatment of patients with non-resectable gastric cancer.Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancer.
P2860
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Three-week combination chemoth ...... ctive study with 159 patients.
@en
type
label
Three-week combination chemoth ...... ctive study with 159 patients.
@en
prefLabel
Three-week combination chemoth ...... ctive study with 159 patients.
@en
P2093
P2860
P1433
P1476
Three-week combination chemoth ...... ctive study with 159 patients.
@en
P2093
Baek-Yeol Ryoo
Heung-Moon Chang
Jae-Lyun Lee
Jung-Hwa Moon
Min-Hee Ryu
Sung-Sook Lee
Tae Won Kim
Yoon-Koo Kang
P2860
P2888
P304
P356
10.1007/S10120-011-0117-2
P50
P577
2011-12-10T00:00:00Z
P5875
P6179
1023367948